JP2003329670A - Reagent for urinary sediment examination and method of urinary sediment examination - Google Patents

Reagent for urinary sediment examination and method of urinary sediment examination

Info

Publication number
JP2003329670A
JP2003329670A JP2002139636A JP2002139636A JP2003329670A JP 2003329670 A JP2003329670 A JP 2003329670A JP 2002139636 A JP2002139636 A JP 2002139636A JP 2002139636 A JP2002139636 A JP 2002139636A JP 2003329670 A JP2003329670 A JP 2003329670A
Authority
JP
Japan
Prior art keywords
reagent
sediment
staining
urinary sediment
urine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002139636A
Other languages
Japanese (ja)
Other versions
JP3875916B2 (en
Inventor
Masaru Matsuoka
優 松岡
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyokuto Pharmaceutical Industrial Co Ltd
Original Assignee
Kyokuto Pharmaceutical Industrial Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyokuto Pharmaceutical Industrial Co Ltd filed Critical Kyokuto Pharmaceutical Industrial Co Ltd
Priority to JP2002139636A priority Critical patent/JP3875916B2/en
Publication of JP2003329670A publication Critical patent/JP2003329670A/en
Application granted granted Critical
Publication of JP3875916B2 publication Critical patent/JP3875916B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

<P>PROBLEM TO BE SOLVED: To provide a reagent for urinary sediment examination that takes place of Steinheimer dyeing reagents and a new method of urinary sediment examination. <P>SOLUTION: An aqueous liquid containing Alcian green and pyronin dye is used as the reagent for urinary sediment examination. The reagent is added to urinary sediments at a ratio (volume ratio) of 1-50:1 (urinary sediments: reagent) and the urinary sediments are observed under a microscope. <P>COPYRIGHT: (C)2004,JPO

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【発明の属する技術分野】本発明は、新規の尿沈渣検査
用試薬及びその試薬を用いる尿沈渣の検査方法に関す
る。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a novel urine sediment inspection reagent and a urine sediment inspection method using the reagent.

【0002】[0002]

【従来の技術】人間ドックを初めとする健康診断では、
尿路疾患、腎炎、癌等の諸疾患発見のための一次スクリ
ーニングとして、尿沈渣を調べる。より具体的には、新
鮮尿を遠心分離にかけて得られる沈澱(尿沈渣)を染色
試薬で染色し、顕微鏡下で赤血球、白血球、上皮細胞、
円柱結晶成分等の有無を観察する。この方法に適用され
ている染色方法は、1975年にSternheime
rによって発表されたステンハイマー染色(A sup
ravital cytodiagnosticsta
in for urinary sediments,
J.A.M.A.,231:826−832,197
5)をその原理とする。
2. Description of the Related Art In medical examinations such as a physical checkup,
Urine sediment is examined as a primary screening for the detection of various diseases such as urinary tract diseases, nephritis, and cancer. More specifically, the precipitate (urine sediment) obtained by centrifuging fresh urine is stained with a staining reagent, and red blood cells, white blood cells, epithelial cells,
Observe the presence or absence of columnar crystal components. The staining method applied to this method was Sternheim, 1975.
Stenheimer Staining (A sup
ravital cytodiagnosticsta
in for urinary sediments,
J. A. M. A. , 231: 826-832, 197.
5) is the principle.

【0003】このステンハイマー染色(以下、「S染色
原法」という)では、核を青色に染色する色素として、
フタロシアニン系塩基色素であるナショナル・ファース
ト・ブルーが、また、細胞質を赤紫色に染色する色素と
して、キサンテン系塩基色素であるピロニンBが使用さ
れている。ところが、日本国においては、従来より、ナ
ショナル・ファースト・ブルーに代わって、同じくフタ
ロシアニン系塩基色素であるアルシアン・ブルーが使用
されてきた。この日本国独特の方法(以下、「S染色変
法」という)は、日本国において、尿沈渣の染色方法と
して広く普及している。このS染色変法は、尿中の円柱
の主成分であるムコタンパクをも染色できるという点に
おいて、S染色原法よりも優れた方法である。
In this Stenheimer dyeing (hereinafter referred to as "S dyeing original method"), as a dye for dyeing the nucleus blue,
National First Blue, which is a phthalocyanine base dye, is used, and Pyronin B, which is a xanthene base dye, is used as a dye that stains the cytoplasm in reddish purple. However, in Japan, Alcian Blue, which is also a phthalocyanine base dye, has been used in place of National First Blue. This method unique to Japan (hereinafter referred to as "S staining modified method") is widely used as a method for staining urinary sediment in Japan. This modified S-staining method is superior to the original S-staining method in that it can also stain mucoprotein, which is the main component of the cast in urine.

【0004】ところが、昨年、諸事情により、アルシア
ン・ブルー(Color Index No.7424
0、C.I.Ingrain Blue 1、市販品の
一例として、Atic Industries社製アル
シアン・ブルー8GXが挙げられる)の製造が中止され
た。従って、アルシアン・ブルーの在庫が底をついた時
点で、より具体的には2〜3年後には、アルシアン・ブ
ルーを含むS染色変法用試薬は入手できなくなる。
However, last year, due to various reasons, Alcian Blue (Color Index No. 7424)
0, C.I. I. Ingrain Blue 1, as an example of a commercially available product, includes Alcian Blue 8GX manufactured by Attic Industries, Inc.) has been discontinued. Therefore, when the stock of Alcian blue has reached the bottom, more specifically, after a few years, the reagent for S-staining modified method containing Alcian blue will not be available.

【0005】[0005]

【発明が解決しようとする課題】上述したように、S染
色変法は、尿沈渣の鏡検を行うための、前処理としての
染色には欠かせない方法である。したがって、アルシア
ン・ブルー以外の色素を用いた、S染色変法用試薬に代
わり得る染色試薬の探索、提供が、臨床検査の現場にお
いて渇望されている。
As described above, the modified S-staining method is an essential method for staining as a pretreatment for performing a microscopic examination of urinary sediment. Therefore, the search and provision of a staining reagent that uses a dye other than Alcian blue and can replace the reagent for the modified S staining method is eagerly desired in the field of clinical examination.

【0006】本発明は、このような状況を踏まえてなさ
れたものであり、尿沈渣の染色に使用される新規の尿沈
渣検査用試薬及びその試薬を用いる尿沈渣の検査方法の
提供を目的とする。
The present invention has been made in view of the above circumstances, and an object thereof is to provide a new urinary sediment inspection reagent used for dyeing urine sediment and a urine sediment inspection method using the reagent. To do.

【0007】[0007]

【課題を解決するための手段】上記課題の解決のため、
本発明者は、鋭意研究を行い、その結果、本発明を完成
させた。
[Means for Solving the Problems] In order to solve the above problems,
The present inventor has conducted earnest research and, as a result, completed the present invention.

【0008】即ち、本発明は、アルシアン・グリーンと
ピロニン染料とを含む水性液体であることを特徴とする
尿沈渣検査用試薬を提供する。
That is, the present invention provides a reagent for examining urinary sediment, which is an aqueous liquid containing Alcian Green and a pyronin dye.

【0009】ピロニン染料として、カラー・インデック
スNo.45005のピロニン及び/又はカラー・イン
デックスNo.45010のピロニンを用いることが好
ましい。
As a pyronin dye, Color Index No. 45005 Pyronin and / or Color Index No. It is preferred to use 45010 of pyronin.

【0010】上記試薬は、さらに、防腐剤及び/又は防
黴剤を含むことが好ましい。
The above reagent preferably further contains an antiseptic and / or an antifungal agent.

【0011】前記水性液体を構成する溶媒として、緩衝
液が好ましく、リン酸緩衝生理食塩水及びトリス緩衝生
理食塩水がより好ましく、10倍濃度のリン酸緩衝生理
食塩水が特に好ましい。
As a solvent constituting the aqueous liquid, a buffer solution is preferable, a phosphate buffered saline and a Tris buffered saline are more preferable, and a phosphate buffered saline having a concentration of 10 times is particularly preferable.

【0012】また、本発明は、尿沈渣に、上記の本発明
の尿沈渣検査用試薬を、尿沈渣:試薬=1〜50:1
(容積比)の割合で加え、顕微鏡下で尿沈渣の一部又は
全部を観察することを含む、尿沈渣の検査方法を提供す
る。
In the present invention, the above-mentioned urinary sediment inspection reagent of the present invention is added to the urine sediment, and the urine sediment: reagent = 1 to 50: 1.
Provided is a method for examining urinary sediment, which comprises observing a part or all of the urinary sediment under a microscope in addition to the ratio (volume ratio).

【0013】前記観察は、尿沈渣に試薬を添加してから
1時間以内に行うのが好ましい。
It is preferable that the observation be performed within 1 hour after the reagent is added to the urine sediment.

【0014】前記観察は、100倍の倍率で全視野につ
いて行うのが好ましい。
It is preferable that the observation is performed at a magnification of 100 for the entire visual field.

【0015】前記観察は、400倍の倍率で必要に応じ
て20以上の視野について行うのが好ましい。
It is preferable that the observation is carried out at a magnification of 400 times for 20 or more visual fields, if necessary.

【0016】[0016]

【発明の実施の形態】以下に、本発明について、詳細に
説明する。
BEST MODE FOR CARRYING OUT THE INVENTION The present invention will be described in detail below.

【0017】本発明の試薬に用いる色素は、アルシアン
・グリーンとピロニン染料である。
The dyes used in the reagent of the present invention are Alcian Green and Pyronine dyes.

【0018】アルシアン・グリーンは、フタロシアニン
系の色素である。アルシアン・グリーンの市販品の例と
して、Imperial Chemical Indu
stries(ICI)社の「アルシアン・グリーン3
BX(Color Index Ingrain Gr
een 1)」とAtic Industries社の
「アルシアン・グリーン2GX(Color Inde
x IngrainGreen 2)」とが挙げられ
る。
Alcian Green is a phthalocyanine dye. As an example of commercial products of Alcian Green, Imperial Chemical Indu
stories (ICI) "Alcian Green 3
BX (Color Index Ingrain Gr
een 1) "and"Industry's"Alcian Green 2GX (Color Inde
x IngrainGreen 2) ”.

【0019】ピロニン染料は、キサンテン(又はザンセ
ン)染料の一種の紅色塩基性染料である。Color
Index No.45000〜45020の色素が、
ピロニン染料に分類される。本発明では、Color
Index(カラー・インデックス)No.45005
のピロニン、及び/又は、Color Index(カ
ラー・インデックス)No.45010のピロニンの使
用が好ましい。C.I.No.45005のピロニンの
市販品の例として、Bayer社製ピロニンGが、ま
た、C.I.No.45010のピロニンの市販品の例
として、Bayer社製ピロニンBが挙げられる。
Pyronine dye is a kind of red basic dye of xanthene (or xanthene) dye. Color
Index No. 45000 to 45020 dyes,
It is classified as a pyronin dye. In the present invention, Color
Index (color index) No. 45005
Pyronin and / or Color Index (Color Index) No. The use of 45010 of pyronin is preferred. C. I. No. As an example of a commercially available product of Pyronin of 450005, Pyronin G manufactured by Bayer Co. I. No. An example of a commercially available product of 45010 Pyronin is Bayer Pyronin B.

【0020】本発明の試薬は、水性液体の形態をとる。
この水性液体を構成する溶媒は、例えば、水(イオン交
換水、蒸留水)及び各種緩衝液である。
The reagent of the present invention is in the form of an aqueous liquid.
The solvent that constitutes this aqueous liquid is, for example, water (ion-exchanged water, distilled water) and various buffer solutions.

【0021】緩衝液の例としては、リン酸緩衝生理食塩
水(PBS、pH7.4付近)、PBS(−)、10×
PBS(試薬濃度が10倍濃いPBS)、トリス塩酸緩
衝液(pH約7.2〜約9.0)、トリス緩衝生理食塩
水(TBS、pH7.4付近)、リン酸ナトリウム緩衝
液(pH約5.7〜約8.0)、クエン酸緩衝液(pH
約3.0〜約5.8)、酢酸緩衝液(pH約3.6〜約
5.6)、グリシン−NaOH緩衝液(pH約8.6〜
約10.6)、ホウ砂緩衝液(pH約9.0〜約10.
6、40℃)、ホウ酸・ホウ砂緩衝液(pH約7.6〜
約9.2)、炭酸・重炭酸緩衝液(pH約9.2〜約1
0.7)、SdrensenとPalitrschの緩
衝液、Walpoleの緩衝液(pH約3.6〜約5.
6)、MeIlvaineの緩衝液(pH約2.2〜約
8.9)、アメジオール緩衝液(pH約7.8〜約9.
2)及びバルビタール緩衝液(pH約7.0〜約8.
9)等が挙げられる。
Examples of the buffer solution include phosphate buffered saline (PBS, around pH 7.4), PBS (-), 10x.
PBS (PBS having a reagent concentration of 10 times higher), Tris-hydrochloric acid buffer solution (pH about 7.2 to about 9.0), Tris-buffered saline (TBS, near pH 7.4), sodium phosphate buffer solution (about pH) 5.7 to about 8.0), citrate buffer (pH
About 3.0 to about 5.8), acetate buffer (pH about 3.6 to about 5.6), glycine-NaOH buffer (pH about 8.6 to
About 10.6), borax buffer (pH about 9.0 to about 10.
6, 40 ° C), boric acid / borax buffer (pH about 7.6-
About 9.2), carbonate / bicarbonate buffer (pH about 9.2 to about 1)
0.7), a buffer of Sdrensen and Palitrsch, and a buffer of Walpole (pH about 3.6 to about 5.
6), MeIlvaine buffer (pH about 2.2 to about 8.9), Amediol buffer (pH about 7.8 to about 9.9).
2) and barbital buffer (pH about 7.0 to about 8.
9) and the like.

【0022】pHが5.0〜9.0、好ましくは6.0
〜8.0、より好ましくは7.0付近の緩衝液を用いる
ことが好ましい。
The pH is 5.0 to 9.0, preferably 6.0.
It is preferable to use a buffer solution of about 8.0, more preferably about 7.0.

【0023】緩衝液の中では、リン酸緩衝生理食塩水
(PBS)及びトリス緩衝生理食塩水(TBS)が好ま
しく、10倍濃度のリン酸緩衝生理食塩水(10×PB
S)を用いると、赤血球の溶血が少ないので、特に好ま
しい。
Among the buffer solutions, phosphate buffered saline (PBS) and Tris buffered saline (TBS) are preferable, and phosphate buffered saline (10 × PB) having a concentration 10 times that of phosphate buffered saline (10 × PB) is used.
Use of S) is particularly preferable because hemolysis of red blood cells is small.

【0024】本発明の試薬は、さらに、防腐剤及び/又
は防黴剤を含むことが好ましい。これらを含むことによ
り、細菌やカビによる試薬の汚染及びそれから派生する
検査結果の誤りを防止できる。
The reagent of the present invention preferably further contains a preservative and / or a fungicide. By including these, it is possible to prevent the contamination of the reagent by bacteria or mold and the error of the test result derived therefrom.

【0025】本発明の試薬に用いる防腐剤の例として
は、ソルビン酸、サリチル酸、デヒドロ酢酸及びそのN
a塩、パラヒドロキシ安息香酸エステル類及びウンデシ
レン酸等の酸類、フェノール、クレゾール、p−クロロ
フェノール、ベンジルアルコール、p−クロロ−m−キ
シレノール、p−クロロ−m−クレゾール、チモール、
フェネチルアルコール、0−フェニルフェノール、イル
ガサン(商標)類、ヘキサクロロフェン及びクロルヘキ
シジン等のフェノール類、エタノール及びクロロブタノ
ール等のアルコール類、及び、塩化ベンザルコニウム、
塩化ベンゼトニウム、塩化セチルピリジニウム、臭化セ
チルトリメチルアンモニウム、塩化ミリスチルジメチル
ベンジルアンモニウム等のカチオン界面活性剤類が挙げ
られる。
Examples of preservatives used in the reagent of the present invention include sorbic acid, salicylic acid, dehydroacetic acid and N 2 thereof.
a salts, acids such as parahydroxybenzoic acid esters and undecylenic acid, phenol, cresol, p-chlorophenol, benzyl alcohol, p-chloro-m-xylenol, p-chloro-m-cresol, thymol,
Phenethyl alcohol, 0-phenylphenol, Irgasan (trademark), phenols such as hexachlorophen and chlorhexidine, alcohols such as ethanol and chlorobutanol, and benzalkonium chloride.
Examples thereof include cationic surfactants such as benzethonium chloride, cetylpyridinium chloride, cetyltrimethylammonium bromide, and myristyldimethylbenzylammonium chloride.

【0026】また、本発明の試薬に用いる防黴剤の例と
しては、塩化ベンザルコニウム、塩化ベンゼトニウム、
塩化セチルピリジニウム、臭化セチルトリメチルアンモ
ニウム、塩化ミリスチルジメチルベンジルアンモニウム
等のカチオン界面活性剤類が挙げられる。
Further, examples of the fungicide used in the reagent of the present invention include benzalkonium chloride, benzethonium chloride,
Examples include cationic surfactants such as cetylpyridinium chloride, cetyltrimethylammonium bromide, myristyldimethylbenzylammonium chloride.

【0027】本発明の試薬(水性液体)は、アルシアン
・グリーンを、例えば0.2〜10重量%、一般的には
0.3〜5重量%、好ましくは0.5〜2.5重量%、
より好ましくは1.0〜1.6重量%、さらにより好ま
しくは1.1〜1.5重量%、最も好ましくは1.2〜
1.4重量%含有する。本発明の試薬は、ピロニン染料
を、例えば0.1〜5重量%、一般的には0.15〜3
重量%、好ましくは0.2〜1.5重量%、より好まし
くは0.2〜0.8重量%、さらにより好ましくは0.
3〜0.7重量%、最も好ましくは0.4〜0.6重量
%含有する。本発明の試薬がカラー・インデックスN
o.45005のピロニン(ピロニンG)とカラー・イ
ンデックスNo.45010のピロニン(ピロニンB)
の両者を含有する場合は、本発明の試薬(水性液体)
は、これらのピロニンを、各々、例えば0.05〜2.
5重量%、一般的には0.075〜1.5重量%、好ま
しくは0.1〜0.75重量%、より好ましくは0.1
〜0.4重量%、さらにより好ましくは0.15〜0.
35重量%、最も好ましくは0.2〜0.3重量%含有
する。カラー・インデックスNo.45005のピロニ
ン(ピロニンG)とカラー・インデックスNo.450
10のピロニン(ピロニンB)の両者を用いると、細胞
質の染色性に特に優れる。
The reagent (aqueous liquid) of the present invention contains Alcian green, for example, 0.2 to 10% by weight, generally 0.3 to 5% by weight, preferably 0.5 to 2.5% by weight. ,
More preferably 1.0-1.6 wt%, even more preferably 1.1-1.5 wt%, most preferably 1.2-
Contains 1.4% by weight. The reagent of the present invention contains a pyronin dye, for example, 0.1 to 5% by weight, generally 0.15 to 3%.
% By weight, preferably 0.2 to 1.5% by weight, more preferably 0.2 to 0.8% by weight, even more preferably 0.
3 to 0.7% by weight, most preferably 0.4 to 0.6% by weight. The reagent of the present invention has a color index N.
o. 45005 Pyronin (Pyronin G) and Color Index No. 45010 Pyronine (Pyronin B)
When both are contained, the reagent of the present invention (aqueous liquid)
Each of these pyronins, for example, 0.05-2.
5% by weight, generally 0.075 to 1.5% by weight, preferably 0.1 to 0.75% by weight, more preferably 0.1.
.About.0.4 wt%, and even more preferably 0.15 to 0.
35% by weight, most preferably 0.2 to 0.3% by weight. Color index No. 45005 Pyronin (Pyronin G) and Color Index No. 450
When both of 10 pyronins (pyronin B) are used, the staining property of the cytoplasm is particularly excellent.

【0028】防腐剤、防黴剤の含有量は、用いる化合物
(防腐剤、防黴剤)の種類による。各防腐剤、防黴剤の
適正含有量は、本技術分野で公知であるが、一例を挙げ
ると、塩化ベンゼトニウムの場合は、一般的には0.0
2〜0.08重量%、好ましくは0.03〜0.07重
量%、より好ましくは0.04〜0.06重量%であ
り、0.05重量%付近が最も好ましい。また、アジ化
ナトリウムの場合は、0.1重量%付近が最善である。
The content of the antiseptic agent and the antifungal agent depends on the kind of the compound (antiseptic agent, antifungal agent) used. The proper content of each antiseptic agent and antifungal agent is known in the technical field, but as an example, in the case of benzethonium chloride, it is generally 0.0
2 to 0.08% by weight, preferably 0.03 to 0.07% by weight, more preferably 0.04 to 0.06% by weight, and most preferably around 0.05% by weight. Further, in the case of sodium azide, the best value is around 0.1% by weight.

【0029】本発明の試薬は、水性液体に、色素類と、
必要に応じて防腐剤、防黴剤を溶解させることで製造す
ることができる。しかし、各色素のストック溶液(溶媒
に色素一種類を溶解させたもの)を用意して、それらを
適当な比率で混合し、要すれば得られた混合物に防腐
剤、防黴剤を溶解させるという方法で製造するのが好ま
しい。
The reagent of the present invention comprises an aqueous liquid, dyes, and
It can be produced by dissolving an antiseptic and a fungicide, if necessary. However, prepare a stock solution of each dye (one kind of dye dissolved in a solvent), mix them at an appropriate ratio, and if necessary, dissolve the preservative and antifungal agent in the resulting mixture. It is preferable to manufacture by the method.

【0030】本発明は、尿沈渣に、上記の本発明の尿沈
渣検査用試薬を、尿沈渣:試薬(容積比)=1〜50:
1、好ましくは3〜30:1、より好ましくは5〜2
0:1、さらにより好ましくは8〜18:1、最も好ま
しくは10〜16:1の割合で加え、顕微鏡下で尿沈渣
の一部又は全部を観察することを含む、尿沈渣の検査方
法を提供する。
In the present invention, the above-mentioned urine sediment inspection reagent of the present invention is added to the urine sediment, and the urine sediment: reagent (volume ratio) = 1 to 50:
1, preferably 3 to 30: 1, more preferably 5 to 2
A method for examining urinary sediment, which comprises observing a part or all of the urinary sediment under a microscope by adding in a ratio of 0: 1, even more preferably 8 to 18: 1, most preferably 10 to 16: 1. provide.

【0031】染色された尿沈渣の顕微鏡による観察は、
尿沈渣中に含まれている成分の細胞質や核が染色された
後に行う。本発明の試薬は、染色性が良好で、しかも濃
染し難いので、前記観察を、尿沈渣に試薬を添加した直
後から2時間後位までの間に行うことができる。なお、
前記観察は、尿沈渣に試薬を添加してから1時間以内に
行うのが好ましい。
Observation of the stained urine sediment by a microscope is as follows.
It is performed after the cytoplasm and nucleus of the components contained in the urine sediment are stained. Since the reagent of the present invention has good dyeability and is hard to be deeply dyed, the observation can be performed from immediately after adding the reagent to the urine sediment to about 2 hours later. In addition,
The observation is preferably performed within 1 hour after adding the reagent to the urine sediment.

【0032】前記観察は、顕微鏡の倍率を100〜40
0倍に設定して行うのが好ましく、100倍又は400
倍の倍率で行うのが特に好ましい。例えば100倍の倍
率で観察する場合には、全視野について観察を行い、ま
た、例えば400倍の倍率で観察する場合には、必要に
応じ、20以上の視野について観察を行うのが好まし
い。100倍の倍率では、通常は、作製した尿沈渣標本
に偏りがないか、沈渣の塊が入っていないか等を判定す
る。400倍の倍率では、各種成分の有無の判定及び数
の算定を行う。
The observation was carried out at a microscope magnification of 100-40.
It is preferable to set it to 0 times, 100 times or 400 times
It is particularly preferable to carry out at a double magnification. For example, when observing at a magnification of 100 times, it is preferable to observe the entire visual field, and when observing at a magnification of 400 times, for example, it is preferable to observe 20 or more visual fields. At a magnification of 100 times, it is usually determined whether or not the prepared urine sediment sample is not biased or does not contain a mass of sediment. At a magnification of 400 times, the presence or absence of various components is determined and the number is calculated.

【0033】従来は、無染色の尿沈渣検体と、検体の状
況によってはS染色変法によって染色した検体につい
て、顕微鏡下での観察を行い、一視野内の赤血球の数、
白血球の数、上皮細胞の量、異型上皮細胞の数、円柱の
数、結晶成分の量等を判定していた。本発明の検査方法
においては、染色した尿沈渣検体を観察するが、無染色
の検体の観察は、検体の状況に応じて行っても行わなく
てもよい。
Conventionally, unstained urine sediment specimens and specimens stained by the S-staining modified method depending on the situation of the specimens were observed under a microscope to determine the number of red blood cells in one visual field,
The number of white blood cells, the amount of epithelial cells, the number of atypical epithelial cells, the number of casts, the amount of crystal components, etc. were determined. In the inspection method of the present invention, the stained urine sediment sample is observed, but the observation of the unstained sample may or may not be performed depending on the condition of the sample.

【0034】[0034]

【実施例】以下に、実施例を示し、本発明をより具体的
に説明する。
EXAMPLES Hereinafter, the present invention will be described more specifically by showing examples.

【0035】(実施例1) (1)尿沈渣が赤血球、白血球、円柱等の固形成分を含
むことが確認された尿を、10mlずつ遠心分離用チュ
ーブに入れ、室温にて、500gで5分間遠心分離し
た。このようにして得られた尿沈渣各々を、表1に示す
色素で染色し、鏡検し、染色性を比較した。染色液は、
青色系のAlcian Green(アルシアン・グリ
ーン)3BX、Victoria Blue(ビクトリ
ア・ブルー)B、Toluidine Blue(トル
イジン・ブルー)N、CresylViolet(クレ
ジル・バイオレット)、Anilin Blue(アニ
リン・ブルー)水溶性、Water Blue(ウォー
ター・ブルー)及びAstra Blue(アストラ・
ブルー)の各色素については1.33重量%の、赤色系
のOrange(オレンジ)G、Pyronine(ピ
ロニン)G及びPyronine(ピロニン)Bの各色
素については0.5重量%の水溶液とした。尿沈渣20
0μlにつき、色素水溶液15μlを使用し、尿沈渣に
色素水溶液を添加した5分後に、顕微鏡下で400倍の
倍率で観察を行った。結果を表1に示す。
(Example 1) (1) 10 ml of urine whose urinary sediment was confirmed to contain solid components such as red blood cells, white blood cells, and casts was placed in a centrifuge tube at room temperature at 500 g for 5 minutes. It was centrifuged. Each of the urine sediments thus obtained was stained with the dyes shown in Table 1 and examined microscopically to compare the staining properties. The stain is
Blue-based Alcian Green 3BX, Victoria Blue B, Toluidine Blue N, Cresyl Violet, Anilin Blue Water-soluble, Water Blue. Water Blue) and Astra Blue (Astra
An aqueous solution of 1.33% by weight for each dye of blue) and 0.5% by weight for each of red (Orange (orange) G, Pyronine (pyronine) G and Pyronine (pyronine) B dyes was prepared. Urine sediment 20
15 μl of an aqueous dye solution was used per 0 μl, and 5 minutes after the aqueous dye solution was added to the urinary sediment, observation was performed under a microscope at a magnification of 400 times. The results are shown in Table 1.

【0036】[0036]

【表1】 [Table 1]

【0037】以上の結果より、アルシアン・グリーン3
BX、アストラ・ブルー、ピロニンG及びピロニンB
が、尿沈渣染色用試薬に用いる色素として使用可能であ
ると考えられた。
From the above results, Alcian Green 3
BX, Astra Blue, Pyronin G and Pyronin B
However, it was considered that it can be used as a dye for a reagent for staining urinary sediment.

【0038】(2)次に、アルシアン・グリーン3BX
とピロニンGとの混合物及びアストラ・ブルーとピロニ
ンGとの混合物の水溶液を用いて、尿沈渣の染色を行っ
た。ピロニンBについては、表1から明らかなようにピ
ロニンGとほぼ同様の結果であったので、ここでは試験
を行わなかった。染色液は、アルシアン・グリーン3B
X又はアストラ・ブルーを1.33重量%と、ピロニン
Gを0.5重量%含む水溶液とした。染色及び観察は、
(1)に記載したものと同様の条件で行った。結果を表
2に示す。
(2) Next, Alcian Green 3BX
The urinary sediment was stained with an aqueous solution of a mixture of aspirin and pyronin G and an aqueous solution of a mixture of astra blue and pyronin G. As is clear from Table 1, the results for Pyronin B were almost the same as those for Pyronin G, so no test was performed here. Staining solution is Alcian Green 3B
An aqueous solution containing 1.33% by weight of X or Astra Blue and 0.5% by weight of Pyronin G was prepared. Staining and observation
It carried out on the same conditions as what was described in (1). The results are shown in Table 2.

【0039】[0039]

【表2】 [Table 2]

【0040】以上の結果より、尿沈渣染色用試薬に用い
る色素の候補として、アルシアン・グリーン3BX、ピ
ロニンG及びピロニンBが選択された。
From the above results, Alcian Green 3BX, Pyronin G and Pyronin B were selected as candidates for the dye used in the reagent for staining urinary sediment.

【0041】(実施例2)尿沈渣染色用試薬に用いる色
素の最適な組合わせの検討のため、アルシアン・グリ
ーン3BXとピロニンG、アルシアン・グリーン3B
XとピロニンB及びアルシアン・グリーン3BX、ピ
ロニンG及びピロニンBを含み、防腐剤としての塩化ベ
ンゼトニウム(和光純薬工業株式会社製、Lot.DW
L−5057、粉末、純度98%以上)をも含む水溶液
を調製した。より具体的には、先ず、アルシアン・グリ
ーン3BXの2重量%水溶液、ピロニンGの1.5重量
%水溶液、ピロニンBの1.5重量%水溶液及び塩化ベ
ンゼトニウムの10重量%水溶液を用意し、表3に記載
の割合でこれらの水溶液を混合した。
(Example 2) In order to examine the optimum combination of dyes used in the reagent for staining urinary sediment, Alcian Green 3BX, Pyronin G, Alcian Green 3B.
X and Pyronin B and Alcian Green 3BX, Pyronin G and Pyronin B, and benzethonium chloride as a preservative (Wako Pure Chemical Industries, Ltd., Lot.DW
L-5057, powder, purity 98% or more) was also prepared. More specifically, first, a 2 wt% aqueous solution of Alcian Green 3BX, a 1.5 wt% aqueous solution of pyronin G, a 1.5 wt% aqueous solution of pyronin B and a 10 wt% aqueous solution of benzethonium chloride were prepared, and These aqueous solutions were mixed in the proportions described in 3.

【0042】[0042]

【表3】 [Table 3]

【0043】これら3種の色素水溶液〜を用いて、
尿沈渣の染色を行った。染色及び観察は、実施例1
(1)に記載したものと同様の条件で行った。結果を表
4に示す。
Using these three types of aqueous dye solutions,
Urine sediment was stained. Staining and observation are done in Example 1
It carried out on the same conditions as what was described in (1). The results are shown in Table 4.

【0044】[0044]

【表4】 [Table 4]

【0045】表4に示すとおり、尿沈渣の染色用試薬と
して、色素水溶液〜のいずれも使用可能であるが、
細胞及び円柱の染色性及び背景のきれいさの点におい
て、色素水溶液が優れていた。
As shown in Table 4, any of aqueous dye solutions can be used as a reagent for staining urinary sediment.
The aqueous dye solution was excellent in terms of stainability of cells and casts and cleanliness of the background.

【0046】次に、水の代わりに10×PBSを用いた
以外は色素水溶液と同様にして、色素水溶液−bを
調製した。この色素水溶液−bを用いて、尿沈渣の染
色及び観察を同様に行った。その結果、細胞質と核との
染め分け及び円柱の染色性などを含む尿沈渣成分の染色
性及び背景のきれいさに関し、色素水溶液を用いた場
合よりもさらに優れていた。
Next, a dye aqueous solution-b was prepared in the same manner as the dye aqueous solution except that 10 × PBS was used instead of water. The dye solution-b was used to similarly stain and observe the urine sediment. As a result, the dyeability of the urinary sediment component including the dyeability of the cytoplasm and the nucleus and the dyeability of the column and the cleanliness of the background were more excellent than those using the aqueous dye solution.

【0047】(実施例3) (1)尿沈渣が赤血球、白血球、円柱等の固形成分を含
むことが確認された尿(検体1〜3)を用意した。検体
1のpHは約5.0であった。検体2のpHは約7.0
であった。検体3のpHは約9.0であった。検体1〜
3各々の比重を比重計(屈折法によるもの)を用いて測
定したところ、いずれも1.015〜1.020の範囲
内であった。
(Example 3) (1) Urine (specimens 1 to 3) was prepared in which the urine sediment was confirmed to contain solid components such as red blood cells, white blood cells and casts. The pH of the sample 1 was about 5.0. The pH of the sample 2 is about 7.0
Met. The pH of the sample 3 was about 9.0. Sample 1
When the specific gravity of each of 3 was measured using a densitometer (by a refraction method), all were in the range of 1.015 to 1.020.

【0048】検体1を、10mlずつ遠心分離用チュー
ブに入れ、室温にて、500gで5分間遠心分離した。
このようにして得られた検体1に由来する尿沈渣各々
(200μl)に、表5に示す染色液のいずれかを、1
5μl添加した。
Specimen 1 was placed in a centrifuge tube by 10 ml and centrifuged at 500 g for 5 minutes at room temperature.
Each of the urinary sediments (200 μl) derived from the specimen 1 thus obtained was treated with one of the staining solutions shown in Table 5.
5 μl was added.

【0049】[0049]

【表5】 [Table 5]

【0050】尿沈渣に染色液を添加した5分後に、顕微
鏡下で200倍もしくは400倍の倍率で溶血しなかっ
た残存赤血球数を数えた。より具体的には、染色液添加
尿沈渣1μl中の赤血球数を算定するために、Neub
auer計算盤を用い、大区画5区画について各々赤血
球数を数え、それらの平均値を求めた。
Five minutes after the addition of the staining solution to the urine sediment, the number of remaining red blood cells that did not undergo hemolysis was counted under a microscope at a magnification of 200 times or 400 times. More specifically, Neub was used to calculate the number of red blood cells in 1 μl of urine sediment containing staining solution.
The number of red blood cells was counted for each of the 5 large sections using an Auer counting board, and the average value thereof was calculated.

【0051】検体2及び3についても、検体1と同様の
処理及び観察を行った。
With respect to the samples 2 and 3, the same processing and observation as in the sample 1 were performed.

【0052】結果を図1及び図2に示す。図1は、溶血
しなかった残存赤血球数を示す棒グラフであり、図2
は、無染色の場合の残存赤血球数に対する各サンプルの
残存赤血球数を百分率で表した結果を示す棒グラフであ
る。
The results are shown in FIGS. 1 and 2. FIG. 1 is a bar graph showing the number of remaining red blood cells that were not hemolyzed.
[Fig. 4] is a bar graph showing the results of expressing the residual red blood cell count of each sample as a percentage with respect to the residual red blood cell count in the case of no staining.

【0053】これらの図から明らかなように、発明例a
を用いると、酸性尿(pH約5.0)では市販のステン
ハイマー染色変法用試薬を用いた場合と同等の、中性尿
(pH約7.0)では市販のステンハイマー染色変法用
試薬を用いた場合よりは少ない、そしてアルカリ尿(p
H約9.0)では市販のステンハイマー染色変法用試薬
を用いた場合よりもやや多い、溶血が見られた。これら
の結果を総合的に判断すると、発明例aは、市販のステ
ンハイマー染色変法用試薬と同等以上の性能を示すとい
える。特に尿が中性の場合には、発明例aを用いて染色
しても無染色と同等の赤血球数であったので、pHが中
性の検体では、無染色での観察を不要とできる可能性が
ある。
As is apparent from these figures, Invention Example a
Is used for acidic urine (pH about 5.0), which is equivalent to the case of using the commercially available reagent for modified Stenheimer staining, and for neutral urine (pH about 7.0), modified for commercially available Stenheimer staining. Less than with reagents, and alkaline urine (p
H about 9.0), hemolysis was observed to be slightly higher than that when a commercially available reagent for modified Stenheimer staining was used. Comprehensively judging from these results, it can be said that the invention example a shows the performance equal to or higher than that of the commercially available reagent for modified Stenheimer staining. Especially, when the urine is neutral, the number of red blood cells was equivalent to that of non-staining even when stained with the invention example a, so that it is possible to eliminate the need for observation without staining in a sample having a neutral pH. There is a nature.

【0054】(2)尿沈渣が赤血球、白血球、円柱等の
固形成分を含むことが確認された尿(pH約7.0)3
種(検体4〜6)を用意した。これらの検体の比重を比
重計(屈折法によるもの)を用いて測定したところ、検
体4は1.005、検体5は1.020、検体6は1.
030であった。
(2) Urine (pH about 7.0) 3 in which the urine sediment was confirmed to contain solid components such as red blood cells, white blood cells and casts.
Species (specimens 4-6) were prepared. When the specific gravities of these samples were measured using a pycnometer (by refractometry), sample 4 was 1.005, sample 5 was 1.020, and sample 6 was 1.
It was 030.

【0055】これ以降は、(1)に記載の方法と同様の
方法により、尿沈渣中の残存赤血球数を数えた。
Thereafter, the number of remaining red blood cells in the urine sediment was counted by the same method as described in (1).

【0056】結果を図3及び図4に示す。図3は、溶血
しなかった残存赤血球数を示す棒グラフであり、図4
は、無染色の場合の残存赤血球数に対する各サンプルの
残存赤血球数を百分率で表した結果を示す棒グラフであ
る。
The results are shown in FIGS. 3 and 4. FIG. 3 is a bar graph showing the number of remaining red blood cells that were not hemolyzed.
[Fig. 4] is a bar graph showing the results of expressing the residual red blood cell count of each sample as a percentage with respect to the residual red blood cell count in the case of no staining.

【0057】これらの図から明らかなように、発明例a
を用いると、低比重尿(比重1.005)では市販のス
テンハイマー染色変法用試薬を用いた場合よりはかなり
少ない、中比重尿(比重1.020)では市販のステン
ハイマー染色変法用試薬を用いた場合よりはやや多い、
そして高比重尿(比重1.030)では市販のステンハ
イマー染色変法用試薬を用いた場合と同等か又はそれよ
りもやや少ない、溶血が見られた。これらの結果を総合
的に判断すると、発明例aは、市販のステンハイマー染
色変法用試薬と同等以上の性能を示すといえる。特に低
比重尿の場合には、発明例aを用いて染色しても無染色
と同等の赤血球数であったので、無染色での観察を不要
とできる可能性がある。
As is clear from these figures, Invention Example a
With low specific gravity urine (specific gravity 1.005), it is considerably less than when using the commercially available reagent for modified Stenheimer's stain. For medium specific gravity urine (specific gravity 1.020), modified for commercially available Stenheimer's stain. A little more than when using reagents,
In high specific gravity urine (specific gravity 1.030), hemolysis was observed, which was equal to or slightly less than the case of using a commercially available reagent for modified Stenheimer staining. Comprehensively judging from these results, it can be said that the invention example a shows the performance equal to or higher than that of the commercially available reagent for modified Stenheimer staining. Particularly, in the case of low specific gravity urine, the number of erythrocytes was the same as that in the case of staining without using the invention example a, so that observation without staining may be unnecessary.

【0058】(実施例4) (1)発明例aの代わりに、以下に示す発明例bを用い
た以外は、実施例3(1)と同様の実験を行った。
Example 4 (1) An experiment similar to that of Example 3 (1) was conducted, except that the invention example b shown below was used instead of the invention example a.

【0059】発明例b:[アルシアン・グリーン3BX
(2重量%)の10×PBS溶液2.0ml]+[ピロ
ニンG(1.5重量%)の10×PBS溶液0.5m
l]+[ピロニンB(1.5重量%)の10×PBS溶
液0.5ml]+[塩化ベンゼトニウム(10重量%)
の水溶液30μl]
Invention Example b: [Alcian Green 3BX
(2 wt%) 10 × PBS solution 2.0 ml] + [pyronin G (1.5 wt%) 10 × PBS solution 0.5 m
l] + [0.5 ml of 10 × PBS solution of pyronin B (1.5% by weight)] + [benzethonium chloride (10% by weight)
Aqueous solution of 30 μl]

【0060】結果を図5に示す。図5は、無染色の場合
に溶血せずに残存した赤血球数に対して、各サンプルの
残存赤血球数を百分率で表した結果を示す棒グラフであ
る。
The results are shown in FIG. FIG. 5 is a bar graph showing the results of expressing the number of remaining red blood cells of each sample as a percentage with respect to the number of red blood cells remaining without hemolysis in the case of no staining.

【0061】図5から明らかなように、発明例bを用い
ると、酸性尿(pH約5.0)及び中性尿(pH約7.
0)では、既存のステンハイマー染色変法用試薬を用い
た場合はもとより、無染色の場合よりも溶血が少なかっ
た。また、アルカリ尿(pH約9.0)の場合も、溶血
は既存のステンハイマー染色変法用試薬を用いた場合と
同等であった。これらの結果を総合的に判断すると、発
明例bは、市販品をはじめとする既存のステンハイマー
染色変法用試薬よりも溶血性が低く、より優れるといえ
る。特に尿が酸性〜中性の場合には、発明例bを用いて
染色したものは、無染色よりも赤血球数が多かったの
で、pHが酸性〜中性の検体については、無染色での観
察を不要とできる可能性がある。
As is apparent from FIG. 5, when the invention example b is used, acidic urine (pH about 5.0) and neutral urine (pH about 7.
In 0), hemolysis was less than in the case of using the existing reagent for modified Stenheimer's staining and not in the case of non-staining. Also, in the case of alkaline urine (pH about 9.0), hemolysis was equivalent to that using the existing reagent for modified Stenheimer staining. Comprehensively judging from these results, it can be said that the invention example b is lower in hemolytic property and superior to the existing reagents for modified Stenheimer staining such as commercial products. Especially when the urine was acidic to neutral, the one stained with Inventive Example b had more red blood cells than the unstained sample. Therefore, the sample with acidic to neutral pH was observed without staining. May be unnecessary.

【0062】(2)発明例aの代わりに発明例bを用い
た以外は、実施例4(2)と同様の実験を行った。
(2) The same experiment as in Example 4 (2) was carried out except that Invention Example b was used instead of Invention Example a.

【0063】結果を図6に示す。図6は、無染色の場合
に溶血せずに残存した赤血球数に対して、各サンプルの
残存赤血球数を百分率で表した結果を示す棒グラフであ
る。
The results are shown in FIG. FIG. 6 is a bar graph showing the results of expressing the number of residual red blood cells of each sample as a percentage with respect to the number of red blood cells remaining without hemolysis in the case of no staining.

【0064】図6から明らかなように、発明例bを用い
ると、低比重尿(比重1.005)では既存のステンハ
イマー染色変法用試薬を用いた場合と同等又はそれより
も少ない、中比重尿(比重1.020)では既存のステ
ンハイマー染色変法用試薬を用いた場合よりも少ない、
そして高比重尿(比重1.030)では市販のステンハ
イマー染色変法用試薬を用いた場合とほぼ同等の、溶血
が見られた。従って、発明例bは、市販品をはじめとす
る既存のステンハイマー染色変法用試薬よりも溶血性が
低く、より優れるといえる。また、発明例bを用いて染
色した場合、いずれの比重の尿も無染色の場合の70%
以上の残存赤血球数を示したので、無染色での観察を不
要とできる可能性がある。
As is apparent from FIG. 6, when the invention sample b is used, low specific gravity urine (specific gravity 1.005) is equivalent to or less than the case of using the existing reagent for modified Stenheimer staining. There is less specific gravity urine (specific gravity 1.020) than when using the existing reagent for modified Stenheimer staining.
In high specific gravity urine (specific gravity 1.030), hemolysis was observed, which was almost the same as when a commercially available reagent for modified Stenheimer staining was used. Therefore, it can be said that Invention Example b has lower hemolytic activity and is more excellent than existing reagents for modified Stenheimer staining, including commercially available products. In addition, when stained using Invention Example b, urine of any specific gravity was 70% of that in the case of no staining.
Since the number of remaining red blood cells is shown above, there is a possibility that observation without staining may be unnecessary.

【0065】[0065]

【発明の効果】本発明の試薬の製造に用いられるアルシ
アン・グリーンは、S染色変法で使用されていたアルシ
アン・ブルーと比べて、水性液体への溶解性に優れる。
従って、尿沈渣の染色用試薬の製造が容易となると共
に、当該試薬の製造に費やされるエネルギーが大いに節
約される。
The alcian green used for the production of the reagent of the present invention is more soluble in an aqueous liquid than the alcian blue used in the modified S dyeing method.
Therefore, the reagent for staining the urinary sediment is easily manufactured, and the energy consumed for manufacturing the reagent is greatly saved.

【0066】本発明の試薬を用いると、既存のS染色変
法用試薬を用いた場合に比べて、被検体が濃染しにく
い。そのため、染色された成分の検出がより容易とな
る。また、同様の理由により、染色された部分とそうで
ない部分とのコントラストが大きく且つその状態がより
長く持続されるため、無染色の検体と染色した検体の両
者を観察する必要性が小さい。即ち、検査は、染色した
検体の鏡検のみでもよいということになり、検査効率が
上昇する。
When the reagent of the present invention is used, the subject is less likely to be deeply stained than in the case where the existing reagent for modified S-staining method is used. Therefore, it becomes easier to detect the dyed component. Further, for the same reason, the contrast between the stained portion and the non-stained portion is large and the state lasts longer, so that it is less necessary to observe both the unstained specimen and the stained specimen. That is, the examination may be only a microscopic examination of the stained specimen, and the examination efficiency is improved.

【0067】本発明の尿沈渣の検査方法では、既存のカ
ラー・アトラスをそのまま用いることができる。従っ
て、臨床検査に携わる者は、尿沈渣の検査のための新た
な技術の習得等を行う必要がない。
In the urinary sediment examination method of the present invention, the existing color atlas can be used as it is. Therefore, a person involved in the clinical examination does not need to learn a new technique for examining the urine sediment.

【0068】アルシアン・グリーンに加え、カラー・イ
ンデックスNo.45005のピロニン(ピロニンG)
とカラー・インデックスNo.45010のピロニン
(ピロニンB)の両者を含有する本発明の試薬を用いる
と、核の染色性に特に優れるため、核内構造の観察がよ
り容易となる。
In addition to Alcian Green, Color Index No. 45005 Pyronine (Pyronin G)
And color index No. When the reagent of the present invention containing both 45010 of pyronin (pyronin B) is used, the dyeing property of the nucleus is particularly excellent, and thus the observation of the intranuclear structure becomes easier.

【0069】溶媒として約10倍濃度のPBS溶液を用
いた本発明の試薬を用いると、赤血球の溶血が生じ難
く、また、染色性も特に優れる。
When the reagent of the present invention using a PBS solution having a concentration of about 10 times is used as a solvent, hemolysis of erythrocytes is less likely to occur, and dyeability is particularly excellent.

【図面の簡単な説明】[Brief description of drawings]

【図1】図1は、3種類のpH値の尿(比重:1.01
5〜1.020)から得られた尿沈渣各々について、既
存のステンハイマー染色変法用試薬と本発明の試薬(水
性媒体:水)を用いて染色を行った後の残存赤血球数を
示す棒グラフである。
FIG. 1 shows urine of three pH values (specific gravity: 1.01).
5 to 1.020) for each urinary sediment, a bar graph showing the number of remaining red blood cells after staining with the existing reagent for modified Stenheimer staining and the reagent of the present invention (aqueous medium: water) Is.

【図2】図2は、図1のデータを、無染色の場合の残存
赤血球数を100%として表した棒グラフである。
FIG. 2 is a bar graph showing the data of FIG. 1 with the residual red blood cell count in the case of no staining being 100%.

【図3】図3は、3種類の比重の尿(pH約7.0)か
ら得られた尿沈渣各々について、既存のステンハイマー
染色変法用試薬と本発明の試薬(水性媒体:水)を用い
て染色を行った後の残存赤血球数を示す棒グラフであ
る。
FIG. 3 shows the existing reagent for modified Stenheimer staining and the reagent of the present invention (aqueous medium: water) for each urine sediment obtained from urine of three types of specific gravity (pH about 7.0). 3 is a bar graph showing the number of remaining red blood cells after being stained with.

【図4】図4は、図3のデータを、無染色の場合の残存
赤血球数を100%として表した棒グラフである。グラ
フである。
FIG. 4 is a bar graph showing the data in FIG. 3 with the residual red blood cell count in the case of no staining being 100%. It is a graph.

【図5】図5は、3種類のpH値の尿(比重:1.01
5〜1.020)から得られた尿沈渣各々について、既
存のステンハイマー染色変法用試薬と本発明の試薬(水
性媒体:10×PBS)を用いて染色を行った後の残存
赤血球数を、無染色の場合の残存赤血球数を100%と
して表した棒グラフである。
FIG. 5 shows urine with three pH values (specific gravity: 1.01).
5 to 1.020), the residual erythrocyte count after staining with the existing reagent for modified Stenheimer staining and the reagent of the present invention (aqueous medium: 10 × PBS) 2 is a bar graph showing the number of remaining red blood cells in the case of no staining as 100%.

【図6】図6は、3種類の比重の尿(pH約7.0)か
ら得られた尿沈渣各々について、既存のステンハイマー
染色変法用試薬と本発明の試薬(水性媒体:10×PB
S)を用いて染色を行った後の残存赤血球数を、無染色
の場合の残存赤血球数を100%として表した棒グラフ
である。
[Fig. 6] Fig. 6 shows the existing reagent for modified Stenheimer staining and the reagent of the present invention (aqueous medium: 10x) for each urine sediment obtained from urine of three types of specific gravity (pH about 7.0). PB
It is a bar graph showing the number of residual red blood cells after staining with S), with the number of residual red blood cells in the case of no staining being 100%.

Claims (10)

【特許請求の範囲】[Claims] 【請求項1】 アルシアン・グリーンとピロニン染料と
を含む水性液体であることを特徴とする尿沈渣検査用試
薬。
1. A reagent for examining urinary sediment, which is an aqueous liquid containing Alcian Green and a pyronin dye.
【請求項2】 ピロニン染料が、カラー・インデックス
No.45005のピロニン及び/又はカラー・インデ
ックスNo.45010のピロニンである、請求項1に
記載の尿沈渣検査用試薬。
2. The color index No. 1 is a pyronine dye. 45005 Pyronin and / or Color Index No. The reagent for urinary sediment examination according to claim 1, which is 45010 of pyronin.
【請求項3】 さらに防腐剤及び/又は防黴剤を含む、
請求項1又は2に記載の尿沈渣検査用試薬。
3. A preservative and / or a fungicide are further included,
The reagent for urinary sediment examination according to claim 1 or 2.
【請求項4】 前記水性液体を構成する溶媒が緩衝液で
ある、請求項1〜3のいずれか1項に記載の尿沈渣検査
用試薬。
4. The urinary sediment examination reagent according to claim 1, wherein the solvent forming the aqueous liquid is a buffer solution.
【請求項5】 前記緩衝液がリン酸緩衝生理食塩水又は
トリス緩衝生理食塩水である、請求項4に記載の尿沈渣
検査用試薬。
5. The reagent for urinary sediment examination according to claim 4, wherein the buffer solution is phosphate buffered saline or Tris buffered saline.
【請求項6】 前記緩衝液が10倍濃度のリン酸緩衝生
理食塩水である、請求項4に記載の尿沈渣検査用試薬。
6. The reagent for urinary sediment examination according to claim 4, wherein the buffer solution is a 10-fold concentrated phosphate buffered saline.
【請求項7】 尿沈渣に、請求項1乃至6のいずれか1
項に記載の試薬を、尿沈渣:試薬=1〜50:1(容積
比)の割合で加え、顕微鏡下で尿沈渣の一部又は全部を
観察することを含む、尿沈渣の検査方法。
7. The urine sediment according to any one of claims 1 to 6.
A method for inspecting urinary sediment, which comprises observing a part or all of the urinary sediment under a microscope by adding the reagent described in the item 1 in a ratio of urine sediment: reagent = 1 to 50: 1 (volume ratio).
【請求項8】 前記観察を、尿沈渣に試薬を添加してか
ら1時間以内に行う、請求項7に記載の尿沈渣の検査方
法。
8. The method for examining urinary sediment according to claim 7, wherein the observation is performed within 1 hour after adding a reagent to the urine sediment.
【請求項9】 前記観察を、100倍の倍率で全視野に
ついて行う、請求項7又は8に記載の尿沈渣の検査方
法。
9. The method for examining urinary sediment according to claim 7, wherein the observation is performed at a magnification of 100 for the entire visual field.
【請求項10】前記観察を、400倍の倍率で必要に応
じて20以上の視野について行う、請求項7又は8に記
載の尿沈渣の検査方法。
10. The method for examining urinary sediment according to claim 7, wherein the observation is carried out at a magnification of 400 times for 20 or more visual fields as needed.
JP2002139636A 2002-05-15 2002-05-15 Urine sediment examination reagent and urine sediment examination method Expired - Fee Related JP3875916B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2002139636A JP3875916B2 (en) 2002-05-15 2002-05-15 Urine sediment examination reagent and urine sediment examination method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002139636A JP3875916B2 (en) 2002-05-15 2002-05-15 Urine sediment examination reagent and urine sediment examination method

Publications (2)

Publication Number Publication Date
JP2003329670A true JP2003329670A (en) 2003-11-19
JP3875916B2 JP3875916B2 (en) 2007-01-31

Family

ID=29700728

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002139636A Expired - Fee Related JP3875916B2 (en) 2002-05-15 2002-05-15 Urine sediment examination reagent and urine sediment examination method

Country Status (1)

Country Link
JP (1) JP3875916B2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013011519A (en) * 2011-06-29 2013-01-17 Mitsubishi Chemical Medience Corp Stabilized highly alkaline reagent and measuring method
CN111175099A (en) * 2019-12-09 2020-05-19 湖北泰康医疗设备有限公司 Method for extracting and flaking humoral cells for bladder cancer examination
WO2022092312A1 (en) * 2020-11-02 2022-05-05 株式会社ヘルスケアシステムズ Reagent, kit and method for storing urine sample

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013011519A (en) * 2011-06-29 2013-01-17 Mitsubishi Chemical Medience Corp Stabilized highly alkaline reagent and measuring method
CN111175099A (en) * 2019-12-09 2020-05-19 湖北泰康医疗设备有限公司 Method for extracting and flaking humoral cells for bladder cancer examination
WO2022092312A1 (en) * 2020-11-02 2022-05-05 株式会社ヘルスケアシステムズ Reagent, kit and method for storing urine sample
WO2022091418A1 (en) * 2020-11-02 2022-05-05 株式会社ヘルスケアシステムズ Reagent, kit, and method for preserving urine sample
JP7122055B1 (en) * 2020-11-02 2022-08-19 株式会社ヘルスケアシステムズ Reagents, kits and methods for storing urine specimens

Also Published As

Publication number Publication date
JP3875916B2 (en) 2007-01-31

Similar Documents

Publication Publication Date Title
JP3886271B2 (en) Reagent for classification counting of erythroblast and classification counting method
US4581223A (en) Individual leukocyte determination by means of differential metachromatic dye sorption
US10774359B2 (en) Cellular analysis of body fluids
US8163471B2 (en) Reagent for sample analysis, kit for sample analysis and method for sample analysis
Larcom et al. Erythrocytes in urinary sediment: Identification and normal limits: With a note on the nature of granular casts
JPH07110328A (en) Dyeing reagent and method for adjusting and using the same
JPH03266999A (en) Reagent for automatic flow sightmetry measurement of sub-population of at least one leukocyte from whole blood and measuring method using said reagent
WO2010013678A1 (en) Reagent for detecting abnormal cell in cervix of uterus, and method for detecting abnormal cell in cervix of uterus by using same
JPH03182562A (en) Compound for quantitative measurement of reticular erythrocyte in whole blood, reagent composition and its use
CN101974609A (en) Pathogenic bacterium liquid-based thin-layer smear detection kit and detection method thereof
JP2013079968A (en) Sample analysis method
CN101042397B (en) Reagent for analyzing urine and method for analyzing urine
Pihet et al. Diagnosis of dermatophytosis: an evaluation of direct examination using MycetColor® and MycetFluo®
Mohammad et al. Phase contrast microscopic examination of urinary erythrocytes to localise source of bleeding: an overlooked technique?
Papayannopoulou et al. Stains for inclusion bodies
JP3875916B2 (en) Urine sediment examination reagent and urine sediment examination method
EP3112863B1 (en) Method for detecting casts and erythrocytes in urine samples
EP3112862B1 (en) Method for urine sample analysis, use of a reagent for urine sample analysis, and use of a reagent kit for urine sample analysis
US3961039A (en) Urinary sediment stain
JP4338206B2 (en) Classification and counting method of erythroblasts
CN105087778A (en) Method and related kit for detecting HER-2/CEP17 gene status based on rare cells
JP2005043365A (en) Reagent composition for analyzing residual leucocyte in blood bank product having reduced number of leucocyte
JP2000187033A (en) Cell stain
Jafari et al. Diagnostic value of immunoperoxidase staining and immunofluorescence in the study of kidney biopsy specimens
US20090035758A1 (en) Method of Measurement of Micronucleated Erythrocyte Populations

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050406

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20061004

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20061024

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20061027

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20091102

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20101102

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20121102

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20121102

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20131102

Year of fee payment: 7

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees